Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
about
Use of endogenous signal sequences for transient production and efficient secretion by moss (Physcomitrella patens) cells.Expression of recombinant vaccines and antibodies in plantsProduction of biologically active recombinant human factor H in PhyscomitrellaMolecular farming on rescue of pharma industry for next generations.Role of complex N-glycans in plant stress tolerance.A CELLULOSE SYNTHASE (CESA) gene essential for gametophore morphogenesis in the moss Physcomitrella patens.Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.Production of complex multiantennary N-glycans in Nicotiana benthamiana plants.Plant glyco-biotechnology on the way to synthetic biologyMoss systems biology en route: phytohormones in Physcomitrella development.Enhanced recovery of a secreted recombinant human growth factor using stabilizing additives and by co-expression of human serum albumin in the moss Physcomitrella patens.On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.Lepidopteran cells, an alternative for the production of recombinant antibodies?Silencing β1,2-xylosyltransferase in Transgenic Tomato Fruits Reveals xylose as Constitutive Component of Ige-Binding Epitopes.Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma.Molecular tools to study Physcomitrella patens.Moss-made pharmaceuticals: from bench to bedside.Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry miceAntibody therapeutics: isotype and glycoform selection.Production of therapeutic antibodies with controlled fucosylation.Plant-derived vaccines and other therapeutics produced in contained systems.Chloroplasts as expression platforms for plant-produced vaccines.Plant-made pharmaceuticals: leading products and production platforms.Evolution of plant-made pharmaceuticals.Glycoprotein production in moss bioreactors.Glyco-engineering in plants to produce human-like N-glycan structures.Challenges in O-glycan engineering of plants.The mechanism of the anticancer function of M1 macrophages and their use in the clinic.Plant biofarming: novel insights for peptide expression in heterologous systems.Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.The potential of Physcomitrella patens as a platform for the production of plant-based vaccines.Glyco-engineering for biopharmaceutical production in moss bioreactors.Photobioreactors with internal illumination - A survey and comparison.Using glyco-engineering to produce therapeutic proteins.Implications of plant glycans in the development of innovative vaccines.Humanizing glycosylation pathways in eukaryotic expression systems.Image analysis supported moss cell disruption in photo-bioreactors.Expression of bioactive anti-CD20 antibody fragments and induction of ER stress response in Arabidopsis seeds.An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice.Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana
P2860
Q24811666-DD274DC9-0BFB-48ED-B8B4-BC7160CA272FQ27027725-7D1FAB54-31D0-4BD7-ABCE-0140D11897F5Q28290970-F47CDD67-68D9-482C-A938-2C3F70D1C3C6Q30252148-3E6F289F-967C-4269-A38D-3252E2D5218CQ33347691-3CB00006-B221-4BF8-B0A1-39B9872E47F0Q33352784-A44868FE-04D6-44A1-84EE-9D22F2E9F428Q33437488-84805B11-7A87-4879-B5F4-6F3FA84A4D1AQ33793024-42326DDB-84A8-4CEE-960F-9560443C617BQ34304795-4AE5A0AA-A319-4A72-8208-985CC380BD7EQ34542861-DED29844-08DB-4971-97CA-2A9310B004F6Q34584997-E11C5007-EE4D-45B3-91D8-166275CCDBDDQ35002326-4C5182C4-DBAF-4F1F-83D6-BBFBD532E83DQ35969904-B6FC9C4F-85AE-485D-8F1E-FCAE9723B693Q35970338-8ECC80C4-BCB3-4BE9-859E-370D94035BB7Q36074726-EDBE626C-5BE9-43C1-AEC7-A7D1EB71DF3CQ36136806-0757BD83-44FE-4A9F-9F07-E8FB29C30101Q36530505-368595B4-E02D-4015-B8B2-6CEC2150637EQ36582247-224D0574-37DF-4C16-8AB6-120BE927789FQ36922260-38A8ACB6-BD55-40FA-8867-E61EA5ACB78CQ37672128-7244F54C-4627-4FE2-99C7-F38CF24D4A72Q37776718-41A80E59-3574-424E-8363-E268A0695D63Q37776719-B6E4B2D8-A7CB-47C0-A55D-25D3A2840BF3Q37859060-0286D722-3E0B-4A26-B3E5-4411BBDF2D29Q37891688-8BE274FE-AD08-4AFD-A447-3EDC67DD4CACQ37940883-8E82FEBD-669B-4B94-877E-FC28A6CC7FD7Q38034471-9A740548-DC9F-4F73-97CB-89026EF5D866Q38046835-F30DD112-0208-4E6A-95C1-85A797E33844Q38059581-537E3978-CB49-410D-8638-250B24147A88Q38063510-7B86277D-52F4-4D6B-8486-EB8D16343388Q38174581-49D94F25-99A6-42C0-860B-F7232C737550Q38176986-65C2F32D-24AD-4B8C-A7C6-853899BA30F1Q38234961-77F40AAF-B198-427E-9F98-0A5D16313C88Q38397295-27DB4F19-4F2B-4E32-BFF9-3ADFC7A085D1Q38547311-CC72CE84-ED66-4B95-8A61-A3765D34ABD3Q38738762-474392C3-8F73-422F-9CB7-6FEDF1E83E2AQ39006079-B2D10D37-F8FA-4638-A441-802F2F6C9048Q40420301-F16DD3C1-6711-4EFB-B71A-31F60130D1B1Q40958186-DDF524BB-52C8-4A03-83FD-53C4B11AA78CQ41725365-913BFB59-8076-4220-9F6C-2F2BCCD340A4Q41878625-A0023D05-5B64-44B6-BEBF-E0F76608A8AC
P2860
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@ast
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@en
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@nl
type
label
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@ast
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@en
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@nl
prefLabel
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@ast
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@en
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@nl
P2093
P1476
Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans
@en
P2093
Anna Koprivova
Axel Hoffmann
Christian Stemmer
Eva L Decker
Gilbert Gorr
Ralf Reski
P304
P356
10.1111/J.1467-7652.2004.00100.X
P407
P577
2004-11-01T00:00:00Z